Certified by Founder Lodge
FPV Ventures
United States - San Francisco, CA
INVESTOR
1 Disclosed Funding Rounds $18,000,000
164 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
FPV Ventures is a new $450M Fund that backs and serves mission-driven founders. FPV is an investor in Canva, Flexport, Guild Education, Xilis, and Manifold Bio. Most of our investors/LPs are
| Company | Date | Round | Raised |
|---|---|---|---|
 Vectara |
July, 17 ,2024 | Series A | $25,000,000 |
 Credo AI |
July, 31 ,2024 | Unknown | $21,000,000 |
 xilis |
July, 13 ,2022 | Series A | $89,000,000 |
 Yendo |
June, 20 ,2023 | Series A | $24,000,000 |
 Formation Bio |
June, 27 ,2024 | Series D | $327,000,000 |
 HumanX |
April, 16 ,2024 | Unknown | $6,000,000 |
 Enveda Biosciences |
April, 25 ,2023 | Series B | $51,000,000 |
| Vectara |
July, 17 ,2024 | Series A | $25,000,000 |
 Galileo |
November, 02 ,2022 | Series A | $18,000,000 |
| Formation Bio |
June, 27 ,2024 | Series D | $327,000,000 |
| Enveda Biosciences |
April, 25 ,2023 | Series B | $51,000,000 |
| Credo AI |
July, 31 ,2024 | Unknown | $21,000,000 |
| Vectara |
July, 17 ,2024 | Series A | $25,000,000 |
| Yendo |
June, 20 ,2023 | Series A | $24,000,000 |
 Aibidia |
May, 16 ,2023 | Series A | $14,124,000 |
| Aibidia |
May, 16 ,2023 | Series A | $14,124,000 |
| Galileo |
November, 02 ,2022 | Series A | $18,000,000 |
| Formation Bio |
June, 27 ,2024 | Series D | $327,000,000 |
| Credo AI |
July, 31 ,2024 | Unknown | $21,000,000 |
| Yendo |
June, 20 ,2023 | Series A | $24,000,000 |
| Yendo |
June, 20 ,2023 | Series A | $24,000,000 |
| Aibidia |
May, 16 ,2023 | Series A | $14,124,000 |
| Vectara |
July, 17 ,2024 | Series A | $25,000,000 |
| Enveda Biosciences |
April, 25 ,2023 | Series B | $51,000,000 |
| Aibidia |
May, 16 ,2023 | Series A | $14,124,000 |
| Enveda Biosciences |
April, 25 ,2023 | Series B | $51,000,000 |
| Credo AI |
July, 31 ,2024 | Unknown | $21,000,000 |
| Formation Bio |
June, 27 ,2024 | Series D | $327,000,000 |
| xilis |
July, 13 ,2022 | Series A | $89,000,000 |
| HumanX |
April, 16 ,2024 | Unknown | $6,000,000 |
| Aibidia |
May, 16 ,2023 | Series A | $14,124,000 |
| Vectara |
July, 17 ,2024 | Series A | $25,000,000 |
| Enveda Biosciences |
April, 25 ,2023 | Series B | $51,000,000 |
| Formation Bio |
June, 27 ,2024 | Series D | $327,000,000 |
| Yendo |
June, 20 ,2023 | Series A | $24,000,000 |
 Strand Therapeutics |
December, 15 ,2022 | Series A | $97,000,000 |
| Formation Bio |
June, 27 ,2024 | Series D | $327,000,000 |
| Vectara |
July, 17 ,2024 | Series A | $25,000,000 |
 Charlie |
November, 01 ,2023 | Series A | $23,000,000 |
| Aibidia |
May, 16 ,2023 | Series A | $14,124,000 |
| Vectara |
July, 17 ,2024 | Series A | $25,000,000 |
| Aibidia |
May, 16 ,2023 | Series A | $14,124,000 |
| xilis |
July, 13 ,2022 | Series A | $89,000,000 |
| Formation Bio |
June, 27 ,2024 | Series D | $327,000,000 |
| Charlie |
November, 01 ,2023 | Series A | $23,000,000 |
| Charlie |
November, 01 ,2023 | Series A | $23,000,000 |
| Vectara |
July, 17 ,2024 | Series A | $25,000,000 |
| Enveda Biosciences |
April, 25 ,2023 | Series B | $51,000,000 |
| Galileo |
November, 02 ,2022 | Series A | $18,000,000 |
| HumanX |
April, 16 ,2024 | Unknown | $6,000,000 |
| Vectara |
July, 17 ,2024 | Series A | $25,000,000 |
| xilis |
July, 13 ,2022 | Series A | $89,000,000 |
| Strand Therapeutics |
December, 15 ,2022 | Series A | $97,000,000 |
| Charlie |
November, 01 ,2023 | Series A | $23,000,000 |
| Aibidia |
May, 16 ,2023 | Series A | $14,124,000 |
| Galileo |
November, 02 ,2022 | Series A | $18,000,000 |
| Yendo |
June, 20 ,2023 | Series A | $24,000,000 |
| Charlie |
November, 01 ,2023 | Series A | $23,000,000 |
| Credo AI |
July, 31 ,2024 | Unknown | $21,000,000 |
 LatticeFlow |
October, 26 ,2022 | Series A | $12,000,000 |
| Charlie |
November, 01 ,2023 | Series A | $23,000,000 |
| Vectara |
July, 17 ,2024 | Series A | $25,000,000 |
| Enveda Biosciences |
April, 25 ,2023 | Series B | $51,000,000 |
| Yendo |
June, 20 ,2023 | Series A | $24,000,000 |
| Vectara |
July, 17 ,2024 | Series A | $25,000,000 |
| xilis |
July, 13 ,2022 | Series A | $89,000,000 |
| xilis |
July, 13 ,2022 | Series A | $89,000,000 |
| Vectara |
July, 17 ,2024 | Series A | $25,000,000 |
| Credo AI |
July, 31 ,2024 | Unknown | $21,000,000 |
| Aibidia |
May, 16 ,2023 | Series A | $14,124,000 |
| HumanX |
April, 16 ,2024 | Unknown | $6,000,000 |
| Vectara |
July, 17 ,2024 | Series A | $25,000,000 |
| Aibidia |
May, 16 ,2023 | Series A | $14,124,000 |
| LatticeFlow |
October, 26 ,2022 | Series A | $12,000,000 |
| Enveda Biosciences |
April, 25 ,2023 | Series B | $51,000,000 |
| Aibidia |
May, 16 ,2023 | Series A | $14,124,000 |
| Vectara |
July, 17 ,2024 | Series A | $25,000,000 |
| Yendo |
June, 20 ,2023 | Series A | $24,000,000 |
| Yendo |
June, 20 ,2023 | Series A | $24,000,000 |
| Yendo |
June, 20 ,2023 | Series A | $24,000,000 |
| Aibidia |
May, 16 ,2023 | Series A | $14,124,000 |
| xilis |
July, 13 ,2022 | Series A | $89,000,000 |
| Formation Bio |
June, 27 ,2024 | Series D | $327,000,000 |
| HumanX |
April, 16 ,2024 | Unknown | $6,000,000 |
| xilis |
July, 13 ,2022 | Series A | $89,000,000 |
| Charlie |
November, 01 ,2023 | Series A | $23,000,000 |
| Aibidia |
May, 16 ,2023 | Series A | $14,124,000 |
| Vectara |
July, 17 ,2024 | Series A | $25,000,000 |
| Enveda Biosciences |
April, 25 ,2023 | Series B | $51,000,000 |
| Formation Bio |
June, 27 ,2024 | Series D | $327,000,000 |
| Enveda Biosciences |
April, 25 ,2023 | Series B | $51,000,000 |
| Strand Therapeutics |
December, 15 ,2022 | Series A | $97,000,000 |
| Yendo |
June, 20 ,2023 | Series A | $24,000,000 |
| HumanX |
April, 16 ,2024 | Unknown | $6,000,000 |
| Aibidia |
May, 16 ,2023 | Series A | $14,124,000 |
| Charlie |
November, 01 ,2023 | Series A | $23,000,000 |
| Formation Bio |
June, 27 ,2024 | Series D | $327,000,000 |
| Formation Bio |
June, 27 ,2024 | Series D | $327,000,000 |
| Charlie |
November, 01 ,2023 | Series A | $23,000,000 |
| Charlie |
November, 01 ,2023 | Series A | $23,000,000 |
| Aibidia |
May, 16 ,2023 | Series A | $14,124,000 |
| Vectara |
July, 17 ,2024 | Series A | $25,000,000 |
| Enveda Biosciences |
April, 25 ,2023 | Series B | $51,000,000 |
| Aibidia |
May, 16 ,2023 | Series A | $14,124,000 |
| Enveda Biosciences |
April, 25 ,2023 | Series B | $51,000,000 |
| Aibidia |
May, 16 ,2023 | Series A | $14,124,000 |
| HumanX |
April, 16 ,2024 | Unknown | $6,000,000 |
| xilis |
July, 13 ,2022 | Series A | $89,000,000 |
| Credo AI |
July, 31 ,2024 | Unknown | $21,000,000 |
| Charlie |
November, 01 ,2023 | Series A | $23,000,000 |
| Aibidia |
May, 16 ,2023 | Series A | $14,124,000 |
| Formation Bio |
June, 27 ,2024 | Series D | $327,000,000 |
| HumanX |
April, 16 ,2024 | Unknown | $6,000,000 |
| Charlie |
November, 01 ,2023 | Series A | $23,000,000 |
| LatticeFlow |
October, 26 ,2022 | Series A | $12,000,000 |
| Vectara |
July, 17 ,2024 | Series A | $25,000,000 |
| Yendo |
June, 20 ,2023 | Series A | $24,000,000 |
| Vectara |
July, 17 ,2024 | Series A | $25,000,000 |
| Vectara |
July, 17 ,2024 | Series A | $25,000,000 |
| Aibidia |
May, 16 ,2023 | Series A | $14,124,000 |
| Charlie |
November, 01 ,2023 | Series A | $23,000,000 |
| xilis |
July, 13 ,2022 | Series A | $89,000,000 |
| Charlie |
November, 01 ,2023 | Series A | $23,000,000 |
| Charlie |
November, 01 ,2023 | Series A | $23,000,000 |
| HumanX |
April, 16 ,2024 | Unknown | $6,000,000 |
| Yendo |
June, 20 ,2023 | Series A | $24,000,000 |
 X1 Card |
July, 18 ,2022 | Series B | $25,000,000 |
| HumanX |
April, 16 ,2024 | Unknown | $6,000,000 |
| Enveda Biosciences |
April, 25 ,2023 | Series B | $51,000,000 |
| Vectara |
July, 17 ,2024 | Series A | $25,000,000 |
| Vectara |
July, 17 ,2024 | Series A | $25,000,000 |
| Yendo |
June, 20 ,2023 | Series A | $24,000,000 |
| Vectara |
July, 17 ,2024 | Series A | $25,000,000 |
| Yendo |
June, 20 ,2023 | Series A | $24,000,000 |
| LatticeFlow |
October, 26 ,2022 | Series A | $12,000,000 |
| Charlie |
November, 01 ,2023 | Series A | $23,000,000 |
| Formation Bio |
June, 27 ,2024 | Series D | $327,000,000 |
| Aibidia |
May, 16 ,2023 | Series A | $14,124,000 |
| Yendo |
June, 20 ,2023 | Series A | $24,000,000 |
| Yendo |
June, 20 ,2023 | Series A | $24,000,000 |
| Aibidia |
May, 16 ,2023 | Series A | $14,124,000 |
| Yendo |
June, 20 ,2023 | Series A | $24,000,000 |
| Charlie |
November, 01 ,2023 | Series A | $23,000,000 |
| Vectara |
July, 17 ,2024 | Series A | $25,000,000 |
| Enveda Biosciences |
April, 25 ,2023 | Series B | $51,000,000 |
| Charlie |
November, 01 ,2023 | Series A | $23,000,000 |
| X1 Card |
July, 18 ,2022 | Series B | $25,000,000 |
| Vectara |
July, 17 ,2024 | Series A | $25,000,000 |
| HumanX |
April, 16 ,2024 | Unknown | $6,000,000 |
| Aibidia |
May, 16 ,2023 | Series A | $14,124,000 |
| Formation Bio |
June, 27 ,2024 | Series D | $327,000,000 |
| Aibidia |
May, 16 ,2023 | Series A | $14,124,000 |
| Formation Bio |
June, 27 ,2024 | Series D | $327,000,000 |
| LatticeFlow |
October, 26 ,2022 | Series A | $12,000,000 |
| Aibidia |
May, 16 ,2023 | Series A | $14,124,000 |
| Yendo |
June, 20 ,2023 | Series A | $24,000,000 |
| Vectara |
July, 17 ,2024 | Series A | $25,000,000 |
 Edera |
September, 19 ,2024 | Seed | $5,000,000 |
| Charlie |
November, 01 ,2023 | Series A | $23,000,000 |
| Charlie |
November, 01 ,2023 | Series A | $23,000,000 |
| Aibidia |
May, 16 ,2023 | Series A | $14,124,000 |
| Charlie |
November, 01 ,2023 | Series A | $23,000,000 |
| Formation Bio |
June, 27 ,2024 | Series D | $327,000,000 |
| Charlie |
November, 01 ,2023 | Series A | $23,000,000 |
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
StratusGrid | $3,000,000 | (Jun 3, 2026)
Mecka | $60,000,000 | (Jun 3, 2026)
Subtle Medical | $33,000,000 | (Jun 3, 2026)
KOSMOS | $5,000,000 | (Jun 3, 2026)
Novellia | $18,000,000 | (Jun 3, 2026)
